Evolus Inc (FRA:EVL)
€ 10.7 0.2 (1.9%) Market Cap: 679.63 Mil Enterprise Value: 722.95 Mil PE Ratio: 0 PB Ratio: 121.74 GF Score: 53/100

Q2 2024 Evolus Inc Earnings Call Transcript

Jul 31, 2024 / 08:30PM GMT
Release Date Price: €11.2
Operator

Good afternoon, everyone, and thank you for standing by. Welcome to Evolus's second-quarter 2024 earnings conference call. As a reminder, today's conference is being recorded and webcast live. (Operator Instructions)

I would now like to turn the conference over to your host, Nareg Sagherian, Vice President and Head of Global Investor Relations and Corporate Communications. Please go ahead.

Nareg Sagherian
Evolus Inc - Vice President, Head of Global Investor Relations and Corporate Communications

Thank you, operator, and welcome to everyone joining us on today's call to review our second-quarter 2024 financial results. Our second-quarter 2024 press release is now on our website at evolus.com. With me today are David Moatazedi, President and Chief Executive Officer; and Sandra Beaver, Chief Financial Officer. Rui Avelar, Chief Medical Officer and Head of R&D, is also with us for the Q&A portion of the call.

Before we begin our discussion, I'd like to note that during our call, our prepared remarks will include forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot